Literature DB >> 3260241

New rat model of Pneumocystis carinii infection.

M S Bartlett1, J A Fishman, S F Queener, M M Durkin, M A Jay, J W Smith.   

Abstract

Rats free of latent Pneumocystis carinii organisms were immunosuppressed with adrenal corticosteroids and transtracheally injected with P. carinii. These animals subsequently developed P. carinii pneumonia. Infection was accomplished by using organisms from infected rat lung or from culture. Diffuse infection was produced with no significant differences in the numbers of organisms found in various lobes of the lungs. Infections progressed over time so that by 6 weeks postinoculation all animals were heavily infected. Infection by transtracheal injection has three advantages over current models. First, transtracheal injection provides a reliable model which is not dependent on naturally occurring latent Pneumocystis infection. Second, transtracheal injection allows the perpetuation of specific Pneumocystis strains. Third, transtracheal injection is a more rapid and economical means of producing severe Pneumocystis pneumonia.

Entities:  

Mesh:

Year:  1988        PMID: 3260241      PMCID: PMC266540          DOI: 10.1128/jcm.26.6.1100-1102.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  10 in total

1.  Fluorogenic substrate detection of viable intracellular and extracellular pathogenic protozoa.

Authors:  P R Jackson; M G Pappas; B D Hansen
Journal:  Science       Date:  1985-01-25       Impact factor: 47.728

2.  Activity of lipid-soluble inhibitors of dihydrofolate reductase against Pneumocystis carinii in culture and in a rat model of infection.

Authors:  S F Queener; M S Bartlett; M A Jay; M M Durkin; J W Smith
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

3.  Activation and transmission in rats of infection with Pneumocystis.

Authors:  J O Hendley; T H Weller
Journal:  Proc Soc Exp Biol Med       Date:  1971-09

4.  Latent Pneumocystis infection of rats, relapse, and chemotherapy.

Authors:  J K Frenkel; J T Good; J A Shultz
Journal:  Lab Invest       Date:  1966-10       Impact factor: 5.662

5.  Nude mouse: a new experimental model for Pneumocystis carinii infection.

Authors:  P D Walzer; V Schnelle; D Armstrong; P P Rosen
Journal:  Science       Date:  1977-07-08       Impact factor: 47.728

6.  Cultivation of Pneumocystis carinii with WI-38 cells.

Authors:  M S Bartlett; P A Verbanac; J W Smith
Journal:  J Clin Microbiol       Date:  1979-12       Impact factor: 5.948

7.  Natural mode of acquisition for de novo infection with Pneumocystis carinii.

Authors:  W T Hughes
Journal:  J Infect Dis       Date:  1982-06       Impact factor: 5.226

8.  Cellular and humoral immune responses of mice subclinically infected with Pneumocystis carinii.

Authors:  T Furuta; K Ueda; K Fujiwara; K Yamanouchi
Journal:  Infect Immun       Date:  1985-02       Impact factor: 3.441

9.  Sources of rats free of latent Pneumocystis carinii.

Authors:  M S Bartlett; M M Durkin; M A Jay; S F Queener; J W Smith
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

10.  Improved rat model for studying Pneumocystis carinii pneumonia.

Authors:  M S Bartlett; S F Queener; M A Jay; M M Durkin; J W Smith
Journal:  J Clin Microbiol       Date:  1987-03       Impact factor: 5.948

  10 in total
  50 in total

1.  Superiority of methylprednisolone over dexamethasone for induction of Pneumocystis carinii infection in rats.

Authors:  A Sukura; T Soveri; L A Lindberg
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

2.  Role of fibronectin in Pneumocystis carinii attachment to cultured lung cells.

Authors:  S T Pottratz; W J Martin
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

Review 3.  Prevention of infection due to Pneumocystis carinii.

Authors:  J A Fishman
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

4.  Phytosterols are present in Pneumocystis carinii.

Authors:  S T Furlong; J A Samia; R M Rose; J A Fishman
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

5.  Close association of Pneumocystis carinii from infected rat lung with culture cells as shown by light and electron microscopy.

Authors:  M S Bartlett; M P Goheen; C H Lee; M M Shaw; M M Durkin; J W Smith
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

6.  Improved rat model of Pneumocystis carinii pneumonia: induced laboratory infections in Pneumocystis-free animals.

Authors:  C J Boylan; W L Current
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

7.  Mouse model for Pneumocystis carinii pneumonia that uses natural transmission to initiate infection.

Authors:  M A Powles; D C McFadden; L A Pittarelli; D M Schmatz
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

8.  Human immunodeficiency virus type 1 infection of human macrophages modulates the cytokine response to Pneumocystis carinii.

Authors:  O Kandil; J A Fishman; H Koziel; P Pinkston; R M Rose; H G Remold
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

9.  Effect of transcription factor GATA-2 on phagocytic activity of alveolar macrophages from Pneumocystis carinii-infected hosts.

Authors:  Mark E Lasbury; Xing Tang; Pamela J Durant; Chao-Hung Lee
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

10.  Microarray studies on effects of Pneumocystis carinii infection on global gene expression in alveolar macrophages.

Authors:  Bi-Hua Cheng; Yunlong Liu; Xiaoling Xuei; Chung-Ping Liao; Debao Lu; Mark E Lasbury; Pamela J Durant; Chao-Hung Lee
Journal:  BMC Microbiol       Date:  2010-04-08       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.